University of Sydney
223
45
64
95
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
4.5%
10 terminated/withdrawn out of 223 trials
90.5%
+3.9% vs industry average
17%
37 trials in Phase 3/4
8%
8 of 95 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (223)
The Baerveldt Versus Paul (BvP) Study: a Registry-based Randomised Controlled Trial.
Role: lead
ROADMAP Clinical Trial
Role: collaborator
Eating Disorders Genetics Initiative 2
Role: collaborator
Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates
Role: collaborator
eCardiacRehab - a Hybrid Patient-Centered eHealth Programme
Role: collaborator
Electronic Cardiac Rehabilitation (eCardiacRehab) Feasibility Study
Role: collaborator
RegoNivo vs Standard of Care Chemotherapy in AGOC
Role: collaborator
30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants
Role: collaborator
A Master Trial Assessing the Technical Feasibility of First-In-Human Real-Time Image Guided Radiation Therapy Methods
Role: lead
Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging
Role: lead
Post-Operative Prediction of PulmonarY Function
Role: lead
PRIORITY-CONNECT 2 Trial
Role: collaborator
Ventilation Imaging to Improve the Quality of Life for Patients With Lung Cancer Treated With Radiation Therapy
Role: lead
Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)
Role: lead
Respiratory Adaptive Computed Tomography: Feasibility Study on Real-Time Gated 4DCT for Lung Cancer Radiotherapy
Role: lead
Collection of Head Images During Radiotherapy
Role: lead
Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy
Role: lead
Patient Experience and Acceptance of Horizontal Rotation
Role: lead
Nano-X Image Guidance: CBCT With Gravity-induced Motion
Role: lead
MRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation Therapy
Role: lead